Medical - Devices
Compare Stocks
2 / 10Stock Comparison
INGN vs PHM
Revenue, margins, valuation, and 5-year total return — side by side.
Residential Construction
INGN vs PHM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Devices | Residential Construction |
| Market Cap | $196M | $22.46B |
| Revenue (TTM) | $351M | $16.83B |
| Net Income (TTM) | $-25M | $2.04B |
| Gross Margin | 47.6% | 26.1% |
| Operating Margin | -9.1% | 16.4% |
| Forward P/E | — | 11.7x |
| Total Debt | $17M | $2.40B |
| Cash & Equiv. | $104M | $2.01B |
INGN vs PHM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Inogen, Inc. (INGN) | 100 | 18.9 | -81.1% |
| PulteGroup, Inc. (PHM) | 100 | 344.1 | +244.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: INGN vs PHM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
INGN is the clearest fit if your priority is growth exposure.
- Rev growth 3.9%, EPS growth 44.1%, 3Y rev CAGR -2.6%
- 3.9% revenue growth vs PHM's -3.5%
PHM carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 7 yrs, beta 1.01, yield 0.8%
- 5.7% 10Y total return vs INGN's -85.3%
- Lower volatility, beta 1.01, Low D/E 18.5%, current ratio 5.91x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.9% revenue growth vs PHM's -3.5% | |
| Quality / Margins | 12.1% margin vs INGN's -7.1% | |
| Stability / Safety | Beta 1.01 vs INGN's 1.10 | |
| Dividends | 0.8% yield; 7-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +16.3% vs INGN's +0.3% | |
| Efficiency (ROA) | 11.4% ROA vs INGN's -8.3%, ROIC 17.2% vs -24.4% |
INGN vs PHM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
INGN vs PHM — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — INGN and PHM each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PHM is the larger business by revenue, generating $16.8B annually — 47.9x INGN's $351M. PHM is the more profitable business, keeping 12.1% of every revenue dollar as net income compared to INGN's -7.1%. On growth, INGN holds the edge at +3.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $351M | $16.8B |
| EBITDAEarnings before interest/tax | -$16M | $2.8B |
| Net IncomeAfter-tax profit | -$25M | $2.0B |
| Free Cash FlowCash after capex | -$9M | $1.6B |
| Gross MarginGross profit ÷ Revenue | +47.6% | +26.1% |
| Operating MarginEBIT ÷ Revenue | -9.1% | +16.4% |
| Net MarginNet income ÷ Revenue | -7.1% | +12.1% |
| FCF MarginFCF ÷ Revenue | -2.6% | +9.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +3.4% | -12.4% |
| EPS Growth (YoY)Latest quarter vs prior year | -20.0% | -30.4% |
Valuation Metrics
INGN leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $196M | $22.5B |
| Enterprise ValueMkt cap + debt − cash | $110M | $22.9B |
| Trailing P/EPrice ÷ TTM EPS | -8.46x | 10.51x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 11.68x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.64x |
| EV / EBITDAEnterprise value multiple | — | 7.35x |
| Price / SalesMarket cap ÷ Revenue | 0.56x | 1.30x |
| Price / BookPrice ÷ Book value/share | 1.02x | 1.80x |
| Price / FCFMarket cap ÷ FCF | — | 12.84x |
Profitability & Efficiency
Evenly matched — INGN and PHM each lead in 4 of 8 comparable metrics.
Profitability & Efficiency
PHM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-13 for INGN. INGN carries lower financial leverage with a 0.09x debt-to-equity ratio, signaling a more conservative balance sheet compared to PHM's 0.19x. On the Piotroski fundamental quality scale (0–9), INGN scores 6/9 vs PHM's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -12.9% | +15.9% |
| ROA (TTM)Return on assets | -8.3% | +11.4% |
| ROICReturn on invested capital | -24.4% | +17.2% |
| ROCEReturn on capital employed | -13.3% | +20.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.09x | 0.19x |
| Net DebtTotal debt minus cash | -$86M | $394M |
| Cash & Equiv.Liquid assets | $104M | $2.0B |
| Total DebtShort + long-term debt | $17M | $2.4B |
| Interest CoverageEBIT ÷ Interest expense | — | 5590.17x |
Total Returns (Dividends Reinvested)
PHM leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PHM five years ago would be worth $19,537 today (with dividends reinvested), compared to $1,079 for INGN. Over the past 12 months, PHM leads with a +16.3% total return vs INGN's +0.3%. The 3-year compound annual growth rate (CAGR) favors PHM at 20.8% vs INGN's -15.3% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +8.4% | -1.6% |
| 1-Year ReturnPast 12 months | +0.3% | +16.3% |
| 3-Year ReturnCumulative with dividends | -39.3% | +76.2% |
| 5-Year ReturnCumulative with dividends | -89.2% | +95.4% |
| 10-Year ReturnCumulative with dividends | -85.3% | +571.2% |
| CAGR (3Y)Annualised 3-year return | -15.3% | +20.8% |
Risk & Volatility
PHM leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
PHM is the less volatile stock with a 1.01 beta — it tends to amplify market swings less than INGN's 1.10 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.10x | 1.01x |
| 52-Week HighHighest price in past year | $9.13 | $144.27 |
| 52-Week LowLowest price in past year | $5.34 | $95.20 |
| % of 52W HighCurrent price vs 52-week peak | +78.8% | +81.0% |
| RSI (14)Momentum oscillator 0–100 | 58.7 | 46.5 |
| Avg Volume (50D)Average daily shares traded | 282K | 1.7M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates INGN as "Buy" and PHM as "Hold". Consensus price targets imply 261.6% upside for INGN (target: $26) vs 20.8% for PHM (target: $141). PHM is the only dividend payer here at 0.76% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $26.00 | $141.22 |
| # AnalystsCovering analysts | 11 | 44 |
| Dividend YieldAnnual dividend ÷ price | — | +0.8% |
| Dividend StreakConsecutive years of raises | — | 7 |
| Dividend / ShareAnnual DPS | — | $0.89 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +5.5% |
PHM leads in 2 of 6 categories (Total Returns, Risk & Volatility). INGN leads in 1 (Valuation Metrics). 2 tied.
INGN vs PHM: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is INGN or PHM a better buy right now?
For growth investors, Inogen, Inc.
(INGN) is the stronger pick with 3. 9% revenue growth year-over-year, versus -3. 5% for PulteGroup, Inc. (PHM). PulteGroup, Inc. (PHM) offers the better valuation at 10. 5x trailing P/E (11. 7x forward), making it the more compelling value choice. Analysts rate Inogen, Inc. (INGN) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — INGN or PHM?
Over the past 5 years, PulteGroup, Inc.
(PHM) delivered a total return of +95. 4%, compared to -89. 2% for Inogen, Inc. (INGN). Over 10 years, the gap is even starker: PHM returned +571. 2% versus INGN's -85. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — INGN or PHM?
By beta (market sensitivity over 5 years), PulteGroup, Inc.
(PHM) is the lower-risk stock at 1. 01β versus Inogen, Inc. 's 1. 10β — meaning INGN is approximately 9% more volatile than PHM relative to the S&P 500. On balance sheet safety, Inogen, Inc. (INGN) carries a lower debt/equity ratio of 9% versus 19% for PulteGroup, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — INGN or PHM?
By revenue growth (latest reported year), Inogen, Inc.
(INGN) is pulling ahead at 3. 9% versus -3. 5% for PulteGroup, Inc. (PHM). On earnings-per-share growth, the picture is similar: Inogen, Inc. grew EPS 44. 1% year-over-year, compared to -24. 3% for PulteGroup, Inc.. Over a 3-year CAGR, PHM leads at 2. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — INGN or PHM?
PulteGroup, Inc.
(PHM) is the more profitable company, earning 12. 8% net margin versus -6. 5% for Inogen, Inc. — meaning it keeps 12. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PHM leads at 17. 3% versus -8. 7% for INGN. At the gross margin level — before operating expenses — INGN leads at 47. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is INGN or PHM more undervalued right now?
Analyst consensus price targets imply the most upside for INGN: 261.
6% to $26. 00.
07Which pays a better dividend — INGN or PHM?
In this comparison, PHM (0.
8% yield) pays a dividend. INGN does not pay a meaningful dividend and should not be held primarily for income.
08Is INGN or PHM better for a retirement portfolio?
For long-horizon retirement investors, PulteGroup, Inc.
(PHM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 01), 0. 8% yield, +571. 2% 10Y return). Both have compounded well over 10 years (PHM: +571. 2%, INGN: -85. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between INGN and PHM?
These companies operate in different sectors (INGN (Healthcare) and PHM (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: INGN is a small-cap quality compounder stock; PHM is a mid-cap deep-value stock. PHM pays a dividend while INGN does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.